US Patent Issued to Intrabio on Nov. 4 for "Therapeutic agents for improved mobility and cognitive function and for treating neurodegenerative diseases and lysosomal storage disorders" (British Inventor)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,614, issued on Nov. 4, was assigned to Intrabio Ltd (Yarnton, Great Britain).

"Therapeutic agents for improved mobility and cognitive function and for treating neurodegenerative diseases and lysosomal storage disorders" was invented by Mallory Factor (Oxford, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides for treating neurodegenerative diseases and lysosomal storage disorders comprising administering leucine, or a pharmaceutically acceptable salt thereof for direct delivery in a subject in need thereof. The disclosure further provides for leucine, or a pharmaceutically acceptable salt thereof for direct d...